Chemomab Therapeutics Ltd ADR (CMMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2018 | 12-2017 | 09-2017 | 12-2016 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 680 | N/A | 0 | 4,564 |
| Receivables | 657 | N/A | 0 | 868 |
| TOTAL | $1,337 | $N/A | $0 | $5,432 |
| Non-Current Assets | ||||
| PPE Net | 250 | N/A | N/A | N/A |
| Other Non-Current Assets | 177 | 0 | 0 | 10 |
| TOTAL | $427 | $N/A | $N/A | $10 |
| Total Assets | $1,764 | $N/A | $0 | $5,655 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 2,036 | N/A | 0 | 0 |
| Accounts payable and accrued liabilities | 3,550 | 0 | 0 | 107 |
| Accrued Expenses | 152 | N/A | 0 | 141 |
| Other current liabilities | N/A | N/A | 0 | 2,111 |
| TOTAL | $5,737 | $N/A | $0 | $2,359 |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,737 | $N/A | $0 | $2,359 |
| Shareholders' Equity | ||||
| Common Shares | 2,781 | N/A | 0 | 0 |
| Retained earnings | -72,425 | N/A | 0 | -53,070 |
| Other shareholders' equity | 2,233 | 0 | 0 | 1,383 |
| TOTAL | $-3,973 | $N/A | $0 | $3,296 |
| Total Liabilities And Equity | $1,764 | $0 | $0 | $5,655 |